期刊文献+

人脐血间充质干细胞预防博来霉素致大鼠肺纤维化效果 被引量:1

Preventive intervention effect of human umbilical cord blood mesenchymal stem cells on pulmonary interstitial fibrosis induced by bleomycin in rats
原文传递
导出
摘要 目的探讨人脐血间充质干细胞(HUCBMSC)对博来霉素所致大鼠肺纤维化的预防性干预效果及可能机制。方法取第2代HUCBMSC培养至第4代;取无特定病原体级5周龄雄性SD大鼠120只随机分为博来霉素组、干细胞干预组、地塞米松干预组和阴性对照组,每组30只。前3组分别经气管注入博来霉素建立肺纤维化模型,干细胞干预组造模后经鼠尾静脉注入5-溴-2-脱氧尿嘧啶核苷(Brdu)标记的HUCBMSC,地塞米松干预组造模后第1天开始连续腹腔注射地塞米松7 d,阴性对照组经气管注入等体积生理氯化钠溶液,在第7、14、28天分别处死各组中的10只动物,肺组织行苏木精-伊红、马松三色染色,碱水解法测定肺羟脯氨酸的水平。结果干细胞干预组第7、14、28天肺组织均可见Brdu标记的干细胞。3个时间点的博来霉素组肺羟脯氨酸水平呈逐渐升高的趋势,第28天达最高水平(P<0.01)。3个时间点干细胞干预组和地塞米松干预组的肺泡炎症及肺纤维化程度均分别较博来霉素组轻,差异均有统计学意义(P<0.05)。结论 HUCBMSC可以定植于受损的肺组织中,并可能在肺纤维化早期有效减轻肺泡炎及肺纤维化。 Objective To observe the preventive intervention effect and possible mechanism of human umbilical cord blood mesenchymal stem cells(HUCBMSC) on pulmonary fibrosis induced by bleomycin in rats.Methods The second generation of HUCBMSC were cultured to the fourth generation.One hundred and twenty specific pathogen free 5-week-old male rats were randomly divided into 4 groups: bleomycin group,stem cell intervention group,dexamethasone intervention group and negative control group.Pulmonary fibrosis was induced in the front 3 groups with bleomycin drop-in to trachea.Then 5-bromo-2-deoxyuridine(Brdu) marked stem cells were injected in stem cell intervention group immediately by tail vein.Dexamethasone was intraperitoneally injected in dexamethasone intervention group for 7 consecutive days.Sodium chloride was intraperitoneally injected in negative control group.At the 7th,14th,28th day,10 rats in each group were executed respectively.Lung tissue was examined with hematoxylin-eosin and Masson staining.Hydroxyproline contents were tested.Results In stem cell intervention group,there were Brdu marked stem cells at the 7th,14th,28th days in lung tissue.The lung hydroxyproline levels in the bleomycin groups at 3 time points showed a gradually rising trend,and reaching the highest at the 28th day(P &lt; 0.01).Milder alveolitis and fibrosis were seen in stem cell intervention group and dexamethasone intervention group,compared with those in bleomycin group(P &lt; 0.05).Conclusion HUCBMSC can colonize the damaged lung tissue,and may effectively reduce the early pulmonary alveolitis and pulmonary fibrosis.
出处 《中国职业医学》 CAS 北大核心 2013年第3期208-212,共5页 China Occupational Medicine
关键词 人脐血间充质干细胞 肺纤维化 羟脯氨酸 Human umbilical cord blood mesenchymal stem cells Pulmonary fibrosis Hydroxyproline
  • 相关文献

参考文献17

  • 1SMITH M R, GANGIREDDY S R, NARALA V R, et al. Curcumininhibits fibrosis-related effects in IPF Fibroblasts and in mice followingbleomycin-induced lung injury [J]. Am J Physiol Lung Cell Mol Phy-siol, 2010,298(5) : L616 -625.
  • 2CHAKRABORTY S, CHOPRA P, HAK A, et al. Hepatocyte growthfactor is an attractive target for the treatment of pulmonary fibrosis[J]. Expert Opin Investig Drugs,2013 ,22(4) :499 -515.
  • 3PARK S, LEE E J. Recent advances in idiopathic pulmonary fibrosis[J]. Tuberc Respir Dis ( Seoul) ,2013 ,74( 1) :1 -6.
  • 4BADI L,WALKER NM, OHTSUKA T, et al. Epithelial interactionsand local engraftment of lung-resident mesenchymal stem cells [ J ].Am J Respir Cell Mol Biol,2011,45(4) :809 -816.
  • 5RAFII H, JUAREZ M M, ALBERTSON T E,et al. A review of cur-rent and novel therapies for idiopathic pulmonary fibrosis[ J]. J Tho-rac Dis,2013 ,5(1) :48 -73.
  • 6CURLEY G F, ANSARI B, HAYES M, et al. Effects of IntratrachealMesenchymal Stromal Cell Therapy during Recovery and Resolutionafter Ventilator-induced Lung Injury [ J ]. Anesthesiology,2013,118(4):924 -932.
  • 7SINCLAIR K, YERKOVICH S T, CHAMBERS D C. Mesenchymalstem cells and the lung[ J]. Respirology,2013 ,18 (3 ) :397 -411.
  • 8YANG Y,HUANF Y, HUANG C,et al. Antifibrosis effects of triter-pene acids of Eriobotrya japonica ( Thunb. ) Lindl. leaf in a ratmodel of bleomycin-induced pulmonary fibrosis[ J]. J Pharm Pharma-col,2012 ,64( 12) :1751 -1760.
  • 9UZUNHAN Y, NUNES H, GILLER T,et al. Innovative therapeuticsfor idiopathic pulmonary fibrosis[ J]. Presse Med,2011 ,40( 12 Ptl ):1100-1112.
  • 10RICHELDI L. Clinical trials of investigational agents for IPF: a re-view of a Cochrane report[ J]. Respir Res ,2013 ,14 ( Suppl 1 ) :S4.

二级参考文献32

  • 1徐小华,许增禄,徐园园,仇文颖,钱晓菁,陈咏梅.骨髓基质干细胞移植选择下调大鼠心肌梗死细胞外基质基因表达[J].解剖学报,2005,36(4):376-380. 被引量:15
  • 2Fu YS Cheng YC Lin MY Cheng H Chu PM Chou SC Shih YH Ko MH Sung MS.Conversion of human umbilical cord mesenchymal stem cells in Wharton's jelly to dopaminergic neurons in vitro: potential therapeutic application for Parkinsonism[J].中国生物学文摘,2006,20(10):22-23. 被引量:140
  • 3田兆方,杜江,王斌,洪小杨,封志纯.大鼠骨髓来源MSCs对新生大鼠高氧肺损伤的影响[J].南方医科大学学报,2007,27(11):1692-1695. 被引量:5
  • 4Abreu SC,Antunes MA,Pelosi P. Mechanisms of cellular therapy in respiratory diseases[J].Intensive Care Medicine,2011.
  • 5Gharaee-Kermani M,Gyetko MR,Hu B. New insights into the pathogenesis and treatment of idiopathic pulmonary fibrosis:a potential role for stem cells in the lung parenchyma and implications for therapy[J].Pharmaceutical Research,2007,(05):819-841.
  • 6Rojas M,Xu J,Woods CR. Bone marrow-derived mesenchymal stem cells in repair of the injured lung[J].American Journal of Respiratory Cell and Molecular Biology,2005,(02):145-152.
  • 7Romanov YA,Svintsitskaya VA,Smirnov VN. Searching for alternative sources of postnatal human mesenchymal stem cells:candidate MSC-like cells from umbilical cord[J].Stem Cells,2003,(01):105-110.doi:10.1634/stemcells.21-1-105.
  • 8Wang HS,Hung SC,Peng ST. Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord[J].Stem Cells,2004,(07):1330-1337.
  • 9Seshareddy K,Troyer D,Weiss ML. Method to isolate mesenchymal-ike cells from Wharton's Jelly of umbilical cord[J].Methods in Cell Biology,2008.101-119.
  • 10Sueblinvong V,Weiss DJ. Stem cells and cell therapy approaches in lung biology and diseases[J].TRANSLATIONAL RESEARCH,2010,(03):188-205.

共引文献20

同被引文献34

  • 1朱洪新,李锦军,覃文新,杨艳华,何祥火,万大方,顾健人.新基因ANGPTL4的克隆及其在血管新生中的功能研究[J].中华医学杂志,2002,82(2):94-99. 被引量:20
  • 2何彦侠,辛建保.实验性肺纤维化形成过程中肺组织血管生成的动态变化[J].中国组织化学与细胞化学杂志,2005,14(1):89-93. 被引量:10
  • 3Kim I,Kim HG,Kim H, et al. Hepatic expression,synthesis andsecretion of a novel fibrinogen/angiopoietin-related protein that pre-vents endothelial-cell apoptosis [ J]. Biochem J,2000,346 ( Pt 3 ):603 -610.
  • 4Wan D, Gong Y, Qin W, et al. Large-scale cDNA transfection scree-ning for genes related to cancer development and progression [ J]. ProeNatl Acad Sci U S A,2004,101 (44) : 15724 -15729.
  • 5Desai U, Lee EC , Chung K, et al. Lipid-lowering effects of anti-an-giopoietin-like 4 antibody recapitulate the lipid phenotype found in an-giopoietin-like 4 knockout mice [ J]. Proc Natl Acad Sci USA,2007,104(28):11766 -11771.
  • 6Koster A, Chao YB,Mosiop M,et al. Transgenic angiopoietin-like(angptl) 4 over expression and targeted disruption of angptl4 and an-gptl3 : regulation of triglyceride metabolism [ J]. Endocrinology, 2005,146(11) :4943 -4950.
  • 7Adachi H,Fujiwara Y,Kondo T,et al. Angptl 4 deficiency improveslipid metabolism, suppresses foam cell formation and protects againstatherosclerosis [ J]. Biochem Biophys Res Commun, 2009,379 (4):806 -811.
  • 8Mandard S,Zandbergen F,van Straten E, et al. The fasting indueedadipose factor/angiopoietin-like protein 4 is physically associated withlipoproteins and governs plasma lipid levels and adiposity [ J]. J BiolChem,2006,281(2) :934 -944.
  • 9Klopper JP, Berenz A, Hays WR, et al. In vivo and microarray ana-lysis of rexinoid-responsive anaplastic thyroid carcinoma [ J]. ClinCancer Res,2008,14(2) :589 -596.
  • 10Ge H,Cha JY,Gopal H,et al. Differential regulation and propertiesof angiopoietin-like proteins 3 and 4[ J]. J Lipid Res,2005 ,46 (7 ):1484 -1490.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部